Search results
-
Blog
Inside The Altascientist: Nonclinical Dermal Study Considerations
Issue 39 of The Altascientist explores challenges and considerations for dermal studies, candidate selection for transdermal drug delivery systems (TDDS), and more
-
Blog
My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference
Martin Turcotte, Scientific Liaison, Altasciences, recaps two notable talks on cell and gene therapy from the 2024 Boston Society Cell and Gene Therapy Conference.
-
Blog
Inside The Altascientist: Unpacking the Bioanalytical and Regulatory Considerations for Antisense Oligonucleotide (ASO) Studies
This issue of The Altascientist explores the necessary regulatory and bioanalytical considerations for using ASOs in therapeutic drug development. Listen now!
-
Blog
Inside The Altascientist: The Benefits of PCR for Your Gene Therapy Programs
Issue 37 of The Altascientist reveals the advantages of Altasciences’ PCR capabilities, and how to integrate them into your gene therapy studies.
-
Blog
Three Platforms Used to Monitor Cytokines and the Complement System
Explore the significance of cytokines and the complement system, and the platforms Altasciences uses for monitoring and mitigating adverse effects.
-
Blog
The Altascientist Issue 36: Navigating the Key Considerations of Your Nonclinical Cell and Gene Therapy Studies
Discover some of the factors to consider when performing nonclinical cell and gene therapy studies. This article takes a cursory look at some of the concerns covered in The Altascientist.